Meclicure SR Tablet
Marketer
Prontocure Pharma Pvt. Ltd.
Salt Composition
Meclizine (50mg) + Folic Acid (5mg)
Overview Meclicure SR Tablet
Vertigo-relieving Meclicure SR Tablets combine medications to manage vertigo symptoms, including nausea, vomiting, and dizziness. Dosage and duration are determined by your physician and should be followed precisely. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence or condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common, usually transient, side effects include vomiting, dry mouth, headache, and tiredness. Persistent side effects warrant medical attention. Due to potential drowsiness, avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided to prevent increased sleepiness.
Uses of Meclicure SR Tablet
Dizziness
Major Benefits of Meclicure SR Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meclicure SR Tablets can be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Meclicure SR Tablet:
- Vomiting
- Dryness in mouth
- Headache
- Fatigue
- Drowsiness
- Allergic reaction
How to use Meclicure SR Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meclicure SR Tablets can be administered with or without food, although consistent timing is recommended.
How Meclicure SR Tablet works:
Meclizine and folic acid are combined in the extended-release Meclicure SR Tablet formulation.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Meclicure SR Tablet with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The use of Meclicure SR Tablets during pregnancy is typically regarded as safe. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Extended-release Meclicure tablets appear safe for breastfeeding mothers. Available data indicate minimal risk to the infant. However, higher or sustained dosages of Meclicure SR tablets might induce drowsiness or other effects in the nursing baby.
DrivingUNSAFE
Taking Meclicure SR Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Meclicure SR Tablets appear to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, though further data is limited. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Meclicure SR Tablet appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Meclicure SR Tablet :
NA
Facts to Know About Meclicure SR Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience |
3,018 People bought this recently